These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 88784)

  • 1. Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma.
    Porcile G; Musso M; Boccardo F; Rosso R; Santi L
    Tumori; 1979 Apr; 65(2):237-40. PubMed ID: 88784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
    Bajetta E; Rovej R; Buzzoni R; Vaglini M; Bonadonna G
    Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L; Zeuli M; Sega FM; Cognetti F
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy in metastatic malignant melanoma: a randomized study of three DTIC-containing combination.
    Wittes RE; Wittes JT; Golbey RB
    Cancer; 1978 Feb; 41(2):415-21. PubMed ID: 343907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy.
    Everall JD; Dowd PM
    Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710
    [No Abstract]   [Full Text] [Related]  

  • 6. Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.
    Nathanson L; Wittenberg BK
    Cancer Treat Rep; 1980 Jan; 64(1):133-7. PubMed ID: 6155208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
    Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U
    Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial.
    Nystrom ML; Steele JP; Shamash J; Neville F; Oliver RT
    Melanoma Res; 2003 Apr; 13(2):197-9. PubMed ID: 12690305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma.
    Young DW; Lever RS; English JS; MacKie RM
    Cancer; 1985 May; 55(9):1879-81. PubMed ID: 2579722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.
    Luikart SD; Kennealey GT; Kirkwood JM
    J Clin Oncol; 1984 Mar; 2(3):164-8. PubMed ID: 6199481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha.
    Legha SS; Ring S; Bedikian A; Plager C; Eton O; Buzaid AC; Papadopoulos N
    Ann Oncol; 1996 Oct; 7(8):827-35. PubMed ID: 8922197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of metastatic malignant melanoma (author's transl)].
    Kühböck J; Pehamberger H; Mach K; Diem E; Kokoschka EM; Pötzi P
    Wien Klin Wochenschr; 1978 Dec; 90(24):856-8. PubMed ID: 84441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of vinblastine, bleomycin, and cisplatin induction followed by dacarbazine and dibromodulcitol maintenance in the treatment of metastatic melanoma. A follow-up study of twenty-two patients.
    Gentile PS; Epremian BE; Seeger J; Hamm JT; Sheth SP
    Am J Clin Oncol; 1988 Dec; 11(6):666-8. PubMed ID: 2461074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
    Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
    Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
    [No Abstract]   [Full Text] [Related]  

  • 15. Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.
    Mulder NH; van der Graaf WT; Willemse PH; Koops HS; de Vries EG; Sleijfer DT
    Br J Cancer; 1994 Oct; 70(4):681-3. PubMed ID: 7522510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma.
    Vuoristo MS; Hahka-Kemppinen M; Parvinen LM; Pyrhönen S; Seppä H; Korpela M; Kellokumpu-Lehtinen P
    Melanoma Res; 2005 Aug; 15(4):291-6. PubMed ID: 16034308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current results with surgery and adjuvant chemotherapy in malignant melanoma].
    Mechl Z; Kopecný J
    Arch Geschwulstforsch; 1986; 56(5):367-71. PubMed ID: 2429631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy or chemoimmunotherapy in the management of primary malignant melanoma of level III, IV, or V.
    Jacquillat C; Banzet P; Civatte J; Puissant A; Cottenot F; Israel L; Belaich S; Chastang C; Maral J
    Recent Results Cancer Res; 1978; 68():346-58. PubMed ID: 111323
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ; Falkson G
    Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Mar; 66(3):567-9. PubMed ID: 6174231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.